# Differential Effects of n-3 and n-6 Polyunsaturated Fatty Acids on Placental and Embryonic Growth and Development in Diabetic Pregnant Mice

**Authors:** Huiying Li, Chuanjing Chen, Shiyi Liu, Yan Shi, Xiaotong Kuang, Xiaolei Song, Duo Li, Kelei Li

PMC · DOI: 10.3390/nu16081182 · Nutrients · 2024-04-16

## TL;DR

This study shows that n-3 and n-6 fatty acids affect placental and embryonic growth differently in diabetic pregnant mice.

## Contribution

The study reveals distinct mechanisms by which n-3 and n-6 PUFAs influence placental and embryonic development in diabetes.

## Key findings

- High-dose n-3 PUFA increased placental weight and levels of VEGF, IGF-1, and IGFBP3.
- n-6 PUFA reduced VEGF and altered specific phospholipid levels in embryos.
- Cer-16:0 in embryos was positively linked to placental growth factors and improved growth ratios.

## Abstract

The present study aimed to investigate the differential effects of n-3 and n-6 polyunsaturated fatty acids (PUFAs) on placental and embryonic development. Pregnant mice were assigned to five groups: healthy control (HC), diabetes mellitus control (DMC), diabetes + low-dose n-3 PUFA (Ln-3), diabetes + high-dose n-3 PUFA (Hn-3), and diabetes + n-6 PUFA (n-6). On E12.5d, the Hn-3 group, but not the n-6 group, had a higher placenta weight. The weight ratio of embryo to placenta in the n-6 group was significantly lower than in the Hn-3 group but higher than in the DMC group. The Hn-3 group had significantly higher protein levels of VEGF, IGF-1, and IGFBP3, while the n-6 group had lower VEGF than the DMC group. Compared with the DMC group, embryonic Cer-16:0 was significantly higher in the Hn-3 group, while embryonic PC (36:6), PC (38:7), and PE (40:7) were significantly lower in the n-6 group. The embryo and placenta weights were positively correlated with placental VEGF, IGFBP3, and embryonic Cer-16:0, and they were negatively correlated with embryonic PC (36:6) and PE (40:7). The weight ratio of embryo to placenta was negatively correlated with embryonic PC (36:6). In addition, embryonic Cer-16:0 was positively correlated with placental VEGF and IGFBP3. In conclusion, n-3 PUFA and n-6 PUFA improved placental and embryonic growth through different mechanisms.

## Linked entities

- **Proteins:** VEGFA (vascular endothelial growth factor A), IGF1 (insulin like growth factor 1), IGFBP3 (insulin like growth factor binding protein 3)
- **Chemicals:** n-3 PUFA (PubChem CID 56842239), PC (36:6) (PubChem CID 52922733), PE (40:7) (PubChem CID 52924596)
- **Diseases:** diabetes mellitus (MONDO:0005015)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, IGFBP3 (insulin like growth factor binding protein 3) [NCBI Gene 3486] {aka BP-53, IBP-3, IBP3, IGFBP-3}
- **Diseases:** PC (MESH:D015324), Diabetic (MESH:D003920)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** n-6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_A1TI)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11054179/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11054179/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC11054179/full.md

---
Source: https://tomesphere.com/paper/PMC11054179